SCHEMBL16250754

SCHEMBL16250754

C[C@H](C[C@H](C)SC(=O)c1ccccc1)SC(=O)c1ccccc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GPR139 Q6DWJ6 1/20 0.45
KMT2A Q03164 3/20 0.45
PGR P06401 1/20 0.42
ADRA2A P08913 1/20 0.42
ADRA2B P18089 1/20 0.42
HTR2A P28223 1/20 0.42
HRH1 P35367 1/20 0.42
KCNH2 Q12809 1/20 0.42
MAPT P10636 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
LMNA P02545 2/20 0.41
XBP1 P17861 1/20 0.41
ATM Q13315 1/20 0.41
NPSR1 Q6W5P4 1/20 0.41
NR4A2 P43354 1/20 0.41
CES1 P23141 5/20 0.40
TSHR P16473 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
KDM4E B2RXH2 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16236134 1.00 GPR139 (0.45) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL19264805 0.92 GPR139 (0.43) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL25627291 0.86 GPR139 (0.44) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL16236260 0.86 HPGD (0.43) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL16235996 0.86 KMT2A (0.44) GPR139KMT2AMAPTSMN1; SMN2LMNA
SCHEMBL6574063 0.85 TSHR (0.45) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL10633126 0.85 TSHR (0.45) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL16235985 0.84 LMNA (0.47) MAPTSMN1; SMN2LMNATSHRTDP1
SCHEMBL28180788 0.83 RAB9A (0.43) GPR139KMT2APGRADRA2AADRA2B
SCHEMBL28266016 0.82 CTSL (0.37) GPR139KMT2APGRADRA2AADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10005860-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2018-06-26 US disclosed
US-10005860-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2018-06-26 US disclosed
EP-2997049-B1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA SRL (IT) 2017-08-23 EP disclosed
US-20170166667-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-06-15 US disclosed
US-20170166667-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-06-15 US disclosed
US-9644051-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-05-09 US disclosed
US-9644051-B2 Catalyst components for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2017-05-09 US disclosed
US-20160090428-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia, s.r.l. (IT) 2016-03-31 US disclosed
US-20160090428-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS Basell Poliolefine Italia, s.r.l. (IT) 2016-03-31 US disclosed
WO-2014184289-A1 CATALYST COMPONENTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE ITALIA S.R.L. (IT) 2014-11-20 WO disclosed
EP-2803679-A1 Catalyst components for the polymerization of olefins Basell Poliolefine Italia S.r.l. (IT) 2014-11-19 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10005860-B2 Catalyst components for the polymerization of olefins OXER1, OXSR1, NR0B2 GPR139 2225/4885KMT2A 2881/4885PGR 308/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.